
Equity Residential (EQR)
NYSEReal EstateReit - ResidentialSnapshot 2026-07-07
Reading EQR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EQR free→
NYSEReal EstateReit - ResidentialSnapshot 2026-07-07
Reading EQR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EQR free→QuarterlyIQ Insights · EQR
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $70.15. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $70 EQR trades at 13× p/ffo, below its 16× p/ffo peer median, but our blended $60 fair value sits below the price. We hold it with medium confidence: our number sits below the analyst range. Analysts target $66–$79. Note: our $60 fair value sits below the entire analyst range ($66–$79). Not investment advice.
$66.00 – $79.00 (median $72.00) · 9 analysts · as of 2026-06-16
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $72.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $50.21 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $36.72 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $27.97 | — | — | TTM | high |
| graham number | 12M | $27.72 | — | — | TTM | high |
| Mgmt guidance | 12M | $24.27 | 16.2 | 1.50 | Mgmt | high |
| Peer P/FCF | 12M | $70.08 | 21.5 | 3.26 | TTM | high |
| Peer P/FFO | 12M | $86.08 | 16.2 | 5.32 | TTM | high |
| Peer P/S | 12M | $49.71 | 7.9 | 6.26 | TTM | high |
| PEG | 12M | $36.11 | 29.6 | 1.22 | TTM | high |
| residual income | 12M | $23.26 | — | — | TTM | high |
| Own P/E history | 12M | $66.54 | 54.5 | 1.22 | TTM | high |
| triangulated | 12M | $18.83 | 16.2 | 1.16 | Triangulated | high |
| Mgmt guidance | 3Y | $40.44 | 16.2 | 2.50 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $72.36 | 21.5 | 3.37 | Hist. CAGR(prov.) | medium |
| Peer P/FFO | 3Y | $99.32 | 16.2 | 6.14 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $70.18 | 7.9 | 8.84 | guidance | medium |
| PEG | 3Y | $64.30 | 29.6 | 2.17 | Analyst | medium |
| Own P/E history | 3Y | $118.50 | 54.5 | 2.17 | Analyst | medium |
| Mgmt guidance | 5Y | $56.83 | 16.2 | 3.51 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $73.93 | 21.5 | 3.44 | Hist. CAGR(prov.) | high |
| Peer P/FFO | 5Y | $109.27 | 16.2 | 6.75 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $74.31 | 7.9 | 9.36 | guidance | high |
| PEG | 5Y | $68.09 | 29.6 | 2.30 | Analyst | high |
| Own P/E history | 5Y | $125.47 | 54.5 | 2.30 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.